Maven Securities LTD Rigel Pharmaceuticals Inc Transaction History
Maven Securities LTD
- $1.61 Billion
- Q1 2024
Shares
2 transactions
Others Institutions Holding RIGL
# of Institutions
123Shares Held
110MCall Options Held
556KPut Options Held
33.9K-
Armistice Capital, LLC New York, NY15.4MShares$153 Million0.31% of portfolio
-
Black Rock Inc. New York, NY14.8MShares$148 Million0.0% of portfolio
-
Morgan Stanley New York, NY14.4MShares$144 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.37MShares$93.5 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT9.24MShares$92.2 Million1.12% of portfolio
About RIGEL PHARMACEUTICALS INC
- Ticker RIGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 172,836,000
- Market Cap $1.72B
- Description
- Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...